Meridian Bioscience, Inc. (NASDAQ:VIVO)

CAPS Rating: 5 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

Recs

0
Player Avatar geomanpa (< 20) Submitted: 8/24/2009 9:59:51 PM : Outperform Start Price: $21.72 VIVO Score: -40.12

Awesome management

Featured Broker Partners


Advertisement